Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Susan Rodriguez Insider Profile
4 Followers
Susan Rodriguez, CCO at Ardelyx, holds 452.80K shares in Ardelyx (Ticker: ARDX), holds 69.23K shares in Heron Therapeutics (Ticker: HRTX). Most recently, Susan Rodriguez Sold ― shares of Ardelyx on Feb 22, 2024 for an estimated value of 60.55K.
Profitable Transactions
5 out of 12 Profitable Transactions
Average Return
-98.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Susan Rodriguez
Susan Rodriguez's Trading History
Ardelyx
Feb 22, 2024
CCO
Informative Sell
60.55K
$2.91M
Heron Therapeutics
Jan 19, 2024
Director
Uninformative Buy
―
$169.61K
List of latest transactions for each holding click on a transaction to see Susan Rodriguez's performance on stock
You May Also Like
Susan Rodriguez insider profile FAQ
What is the percentage of profitable transactions made by Susan Rodriguez?
The percentage of profitable transactions made by Susan Rodriguez is 42%.
What is the average return per transaction made by Susan Rodriguez?
The average return per transaction made by Susan Rodriguez is -98.60%.
What stocks does Susan Rodriguez hold?
Susan Rodriguez holds: ARDX, HRTX stocks.
What was Susan Rodriguez’s latest transaction?
Susan Rodriguez latest transaction was an Informative Sell of $60.55K.
What was Susan Rodriguez's most profitable transaction?
Susan Rodriguez’s most profitable transaction was an Informative Sell of ARDX stock on May 21, 2021. The return on the trade was 90.60%.
What is Susan Rodriguez's role in Ardelyx?
Susan Rodriguez's role in Ardelyx is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.